Natixis Advisors LLC Grows Stock Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Natixis Advisors LLC grew its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 2.2% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 526,809 shares of the medical equipment provider’s stock after acquiring an additional 11,381 shares during the period. Natixis Advisors LLC owned 0.15% of Intuitive Surgical worth $258,805,000 at the end of the most recent reporting period.

Other institutional investors have also modified their holdings of the company. Capital World Investors increased its holdings in shares of Intuitive Surgical by 1.0% in the 1st quarter. Capital World Investors now owns 7,284,269 shares of the medical equipment provider’s stock valued at $2,907,079,000 after acquiring an additional 73,634 shares during the period. Baillie Gifford & Co. boosted its position in Intuitive Surgical by 0.6% during the third quarter. Baillie Gifford & Co. now owns 3,848,547 shares of the medical equipment provider’s stock valued at $1,890,676,000 after purchasing an additional 24,183 shares in the last quarter. American Century Companies Inc. grew its stake in Intuitive Surgical by 3.0% in the second quarter. American Century Companies Inc. now owns 2,398,193 shares of the medical equipment provider’s stock valued at $1,066,837,000 after purchasing an additional 70,556 shares during the last quarter. Clearbridge Investments LLC raised its holdings in Intuitive Surgical by 1.6% in the second quarter. Clearbridge Investments LLC now owns 1,981,297 shares of the medical equipment provider’s stock worth $881,380,000 after purchasing an additional 30,449 shares in the last quarter. Finally, Assenagon Asset Management S.A. lifted its position in shares of Intuitive Surgical by 15.4% during the second quarter. Assenagon Asset Management S.A. now owns 1,483,406 shares of the medical equipment provider’s stock valued at $659,893,000 after buying an additional 197,841 shares during the last quarter. 83.64% of the stock is owned by hedge funds and other institutional investors.

Intuitive Surgical Price Performance

ISRG stock opened at $527.61 on Friday. The firm’s fifty day simple moving average is $499.29 and its 200-day simple moving average is $457.28. Intuitive Surgical, Inc. has a 12 month low of $295.02 and a 12 month high of $544.38. The company has a market capitalization of $187.92 billion, a P/E ratio of 84.82, a price-to-earnings-growth ratio of 5.28 and a beta of 1.39.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 EPS for the quarter, beating the consensus estimate of $1.24 by $0.32. The company had revenue of $2.04 billion for the quarter, compared to analyst estimates of $2.01 billion. Intuitive Surgical had a net margin of 28.51% and a return on equity of 13.41%. As a group, sell-side analysts forecast that Intuitive Surgical, Inc. will post 5.45 earnings per share for the current year.

Insider Buying and Selling

In related news, insider Jamie Samath sold 22,903 shares of the stock in a transaction on Friday, November 8th. The shares were sold at an average price of $525.00, for a total transaction of $12,024,075.00. Following the sale, the insider now directly owns 8,757 shares of the company’s stock, valued at approximately $4,597,425. This represents a 72.34 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. Also, General Counsel Gary Loeb sold 300 shares of the firm’s stock in a transaction on Monday, September 9th. The shares were sold at an average price of $475.00, for a total transaction of $142,500.00. Following the sale, the general counsel now owns 1,595 shares in the company, valued at approximately $757,625. This represents a 15.83 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 91,178 shares of company stock valued at $45,897,071 over the last ninety days. Company insiders own 0.90% of the company’s stock.

Analyst Ratings Changes

ISRG has been the topic of a number of analyst reports. Raymond James lifted their price objective on shares of Intuitive Surgical from $500.00 to $540.00 and gave the stock an “outperform” rating in a research report on Monday, October 14th. Mizuho lifted their price target on shares of Intuitive Surgical from $440.00 to $500.00 in a report on Thursday, October 17th. Leerink Partners increased their price objective on Intuitive Surgical from $489.00 to $502.00 in a report on Thursday, October 17th. Truist Financial boosted their target price on Intuitive Surgical from $520.00 to $570.00 and gave the stock a “buy” rating in a research note on Monday, October 14th. Finally, Robert W. Baird upped their target price on Intuitive Surgical from $503.00 to $565.00 and gave the company an “outperform” rating in a research report on Thursday, October 17th. One analyst has rated the stock with a sell rating, five have assigned a hold rating and fourteen have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $513.74.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.